The VET PFAS Act expands VA healthcare and disability benefits for veterans and their families exposed to toxic PFAS chemicals at military installations by establishing presumptions of service connection for related illnesses.
Michael Lawler
Representative
NY-17
The VET PFAS Act expands healthcare and disability benefits for veterans and their families exposed to toxic PFAS chemicals, like PFOA, at contaminated military installations. It establishes a presumption of service connection for specific related illnesses, making it easier for veterans to receive disability compensation. Furthermore, the bill grants eligible family members access to VA medical care, contingent upon future appropriations. The VA is also required to report annually on the implementation and utilization of these new provisions for three years.
The Veterans Exposed to Toxic PFAS Act, or the VET PFAS Act, is a major shift in how the VA handles claims related to toxic chemical exposure on military bases. Starting 90 days after enactment, this bill establishes two crucial things: immediate VA healthcare access and a presumption of service connection for certain illnesses linked to PFAS chemicals, specifically PFOA, found in contaminated drinking water at military installations.
If you served at a military base where PFOA contamination occurred, this bill automatically presumes that specific illnesses are service-connected, meaning you don't have to spend years fighting the VA to prove the link. For exposure to PFOA, the list of covered conditions includes high cholesterol, ulcerative colitis, thyroid disease, testicular cancer, kidney cancer, and pregnancy-induced hypertension (SEC. 3). This is huge because it removes the heaviest burden of proof from the veteran—the need to show a direct causal link between their service and their current illness.
For veterans exposed to other PFAS chemicals, the VA Secretary must first determine a “positive link” based on a mandated 2018 study before those illnesses are covered under this presumption (SEC. 3). While this keeps the door open for future coverage, it also means that for non-PFOA exposure, the automatic benefit isn't immediate, depending instead on administrative review and discretion.
Beyond disability benefits, the VET PFAS Act grants eligible veterans immediate access to VA hospital care and medical services for the same covered illnesses, regardless of whether a service connection has been formally established (SEC. 2). This means treatment can start right away, which is critical when dealing with serious conditions like cancer or kidney disease. Critically, this provision also applies to reservists whose time at a contaminated base will now count as active service for eligibility.
In a significant expansion, the bill also extends this healthcare eligibility to family members—spouses and children—who lived at the contaminated military installation while the veteran was stationed there (SEC. 2). This acknowledges that the toxic exposure affected the whole family, not just the service member. For example, a veteran’s child who developed thyroid disease after living on base could now seek care through the VA.
While the family care expansion is a major win, it comes with a couple of administrative speed bumps. First, the VA is only authorized to provide this family care if Congress sets aside specific funding for it in the budget (SEC. 2). If the money isn't appropriated, the benefit won't materialize, which introduces uncertainty for families planning on using this coverage.
Second, before the VA pays for a family member's care, the family member or their provider must first try—and fail—to get payment from any other available source, like a private insurance company (SEC. 2). This means the VA acts as the payer of last resort, which could add layers of administrative hassle and delay for families already dealing with complex medical issues.
Finally, to ensure accountability, the VA Secretary must submit annual reports to Congress for three years detailing how many veterans and family members received care, the conditions treated, and how many applications were denied, including the reasons for denial (SEC. 2). This reporting requirement brings much-needed transparency to the rollout of these new, life-changing benefits.